{"id":47624,"date":"2022-08-24T17:01:43","date_gmt":"2022-08-24T15:01:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/"},"modified":"2022-08-24T17:01:43","modified_gmt":"2022-08-24T15:01:43","slug":"global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/","title":{"rendered":"Global Gynecological Cancer Drugs Market Report 2022: High Incidence of Gynecological Cancers, Growth in the Importance of Targeted Drug Therapies &amp; Increase in Government Investments Driving Growth &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5640609\/gynecological-cancer-drugs-market-by-therapeutic?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=j38tkl&amp;utm_campaign=1741859+-+Global+Gynecological+Cancer+Drugs+Market+Report+2022%3A+High+Incidence+of+Gynecological+Cancers%2C+Growth+in+the+Importance+of+Targeted+Drug+Therapies+%26+Increase+in++Government+Investments+Driving+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Gynecological Cancer Drugs Market By Therapeutic Modality, By Indication: Global Opportunity Analysis and Industry Forecast, 2020-2030&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220824005598\/en\/1552628\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220824005598\/en\/1552628\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe key factors that drive the market growth include, the high incidence of gynecological cancers, growth in the importance of targeted drug therapies, an increase in investment from government, public, &amp; private sectors for cancer treatment, and a surge in the number of product approval for gynecological cancer drugs.\n<\/p>\n<p>\nHowever, the high cost of drug development and the threat of failure &amp; adverse effects of cancer drug therapy on a patient&#8217;s body restrain this growth. The advancement of cancer drug research and the advent of personalized medicine approaches are expected to provide numerous opportunities for market growth during the forecast period.\n<\/p>\n<p>\nThe gynecological cancer drugs market is segmented into therapeutic modality, indication, and region. By therapeutic modality, the market is divided into chemotherapy, targeted therapy, and hormonal therapy. The indications segment is categorized into uterine cancer, ovarian cancer, vaginal &amp; vulvar cancer, and cervical cancer. By region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).\n<\/p>\n<p>\n<strong>Key Benefits For Stakeholders<\/strong>\n<\/p>\n<ul>\n<li>\nThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pneumonia testing market analysis from 2020 to 2030 to identify the prevailing pneumonia testing market opportunities.\n<\/li>\n<li>\nThe market research is offered along with information related to key drivers, restraints, and opportunities.\n<\/li>\n<li>\nPorter&#8217;s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.\n<\/li>\n<li>\nIn-depth analysis of the pneumonia testing market segmentation assists to determine the prevailing market opportunities.\n<\/li>\n<li>\nMajor countries in each region are mapped according to their revenue contribution to the global market.\n<\/li>\n<li>\nMarket player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.\n<\/li>\n<li>\nThe report includes the analysis of the regional as well as global pneumonia testing market trends, key players, market segments, application areas, and market growth strategies.\n<\/li>\n<\/ul>\n<p>\n<strong>Key Market Segments<\/strong>\n<\/p>\n<p>\n<strong>By Indication<\/strong>\n<\/p>\n<ul>\n<li>\nCervical Cancer\n<\/li>\n<li>\nUterine Cancer\n<\/li>\n<li>\nOvarian Cancer\n<\/li>\n<li>\nVaginal Vulvar Cancer\n<\/li>\n<\/ul>\n<p>\n<strong>By Therapeutic Modality<\/strong>\n<\/p>\n<ul>\n<li>\nChemotherapy\n<\/li>\n<li>\nTargeted Therapy\n<\/li>\n<li>\nHormonal Therapy\n<\/li>\n<\/ul>\n<p>\n<strong>By Region<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nU.S.\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nGermany\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nU.K.\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nRest of Europe\n<\/li>\n<li>\nAsia-Pacific\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nChina\n<\/li>\n<li>\nAustralia\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nRest Of Asia Pacific\n<\/li>\n<li>\nLAMEA\n<\/li>\n<li>\nBrazil\n<\/li>\n<li>\nSaudi Arabia\n<\/li>\n<li>\nSouth Africa\n<\/li>\n<li>\nRest of LAMEA\n<\/li>\n<\/ul>\n<p>\n<strong>Key Market Players<\/strong>\n<\/p>\n<ul>\n<li>\nApotex\n<\/li>\n<li>\nAstrazeneca\n<\/li>\n<li>\nBristol-Myers Squibb Company\n<\/li>\n<li>\nEli Lilly and Company\n<\/li>\n<li>\nF. Hoffmann-La Roche\n<\/li>\n<li>\nGlaxoSmithKline\n<\/li>\n<li>\nMerck &amp; Co.\n<\/li>\n<li>\nNovartis\n<\/li>\n<li>\nPfizer\n<\/li>\n<li>\nTeva Pharmaceutical Industries\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 1: INTRODUCTION<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 2: EXECUTIVE SUMMARY<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 3: MARKET OVERVIEW<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 4: GYNECOLOGICAL CANCER DRUGS MARKET, BY THERAPEUTIC MODALITY<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 5: GYNECOLOGICAL CANCER DRUGS MARKET, BY INDICATION<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 6: GYNECOLOGICAL CANCER DRUGS MARKET, BY REGION<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 7: COMPANY LANDSCAPE<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 8: COMPANY PROFILES<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5640609\/gynecological-cancer-drugs-market-by-therapeutic?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=j38tkl&amp;utm_campaign=1741859+-+Global+Gynecological+Cancer+Drugs+Market+Report+2022%3A+High+Incidence+of+Gynecological+Cancers%2C+Growth+in+the+Importance+of+Targeted+Drug+Therapies+%26+Increase+in++Government+Investments+Driving+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/agzqew<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;o:&#112;&#114;&#x65;&#x73;s&#64;&#114;&#101;&#x73;&#x65;ar&#99;&#x68;&#x61;&#x6e;d&#109;&#97;&#x72;&#x6b;&#x65;t&#115;&#46;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">pr&#101;&#115;&#115;&#x40;&#x72;&#x65;&#x73;&#x65;ar&#99;&#104;&#97;&#x6e;&#x64;&#x6d;&#x61;&#x72;ke&#116;&#115;&#46;&#x63;&#x6f;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Gynecological Cancer Drugs Market By Therapeutic Modality, By Indication: Global Opportunity Analysis and Industry Forecast, 2020-2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The key factors that drive the market growth include, the high incidence of gynecological cancers, growth in the importance of targeted drug therapies, an increase in investment from government, public, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-47624","format-standard","category-industry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Gynecological Cancer Drugs Market Report 2022: High Incidence of Gynecological Cancers, Growth in the Importance of Targeted Drug Therapies &amp; Increase in Government Investments Driving Growth - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Gynecological Cancer Drugs Market Report 2022: High Incidence of Gynecological Cancers, Growth in the Importance of Targeted Drug Therapies &amp; Increase in Government Investments Driving Growth - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Gynecological Cancer Drugs Market By Therapeutic Modality, By Indication: Global Opportunity Analysis and Industry Forecast, 2020-2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The key factors that drive the market growth include, the high incidence of gynecological cancers, growth in the importance of targeted drug therapies, an increase in investment from government, public, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-24T15:01:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220824005598\/en\/1552628\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Gynecological Cancer Drugs Market Report 2022: High Incidence of Gynecological Cancers, Growth in the Importance of Targeted Drug Therapies &amp; Increase in Government Investments Driving Growth &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-08-24T15:01:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\\\/\"},\"wordCount\":574,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220824005598\\\/en\\\/1552628\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\\\/\",\"name\":\"Global Gynecological Cancer Drugs Market Report 2022: High Incidence of Gynecological Cancers, Growth in the Importance of Targeted Drug Therapies &amp; Increase in Government Investments Driving Growth - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220824005598\\\/en\\\/1552628\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-08-24T15:01:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220824005598\\\/en\\\/1552628\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220824005598\\\/en\\\/1552628\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Gynecological Cancer Drugs Market Report 2022: High Incidence of Gynecological Cancers, Growth in the Importance of Targeted Drug Therapies &amp; Increase in Government Investments Driving Growth &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Gynecological Cancer Drugs Market Report 2022: High Incidence of Gynecological Cancers, Growth in the Importance of Targeted Drug Therapies &amp; Increase in Government Investments Driving Growth - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/","og_locale":"en_US","og_type":"article","og_title":"Global Gynecological Cancer Drugs Market Report 2022: High Incidence of Gynecological Cancers, Growth in the Importance of Targeted Drug Therapies &amp; Increase in Government Investments Driving Growth - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Gynecological Cancer Drugs Market By Therapeutic Modality, By Indication: Global Opportunity Analysis and Industry Forecast, 2020-2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The key factors that drive the market growth include, the high incidence of gynecological cancers, growth in the importance of targeted drug therapies, an increase in investment from government, public, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-24T15:01:43+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220824005598\/en\/1552628\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Gynecological Cancer Drugs Market Report 2022: High Incidence of Gynecological Cancers, Growth in the Importance of Targeted Drug Therapies &amp; Increase in Government Investments Driving Growth &#8211; ResearchAndMarkets.com","datePublished":"2022-08-24T15:01:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/"},"wordCount":574,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220824005598\/en\/1552628\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/","url":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/","name":"Global Gynecological Cancer Drugs Market Report 2022: High Incidence of Gynecological Cancers, Growth in the Importance of Targeted Drug Therapies &amp; Increase in Government Investments Driving Growth - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220824005598\/en\/1552628\/21\/logo.jpg","datePublished":"2022-08-24T15:01:43+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220824005598\/en\/1552628\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220824005598\/en\/1552628\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-gynecological-cancer-drugs-market-report-2022-high-incidence-of-gynecological-cancers-growth-in-the-importance-of-targeted-drug-therapies-increase-in-government-investments-driving-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Gynecological Cancer Drugs Market Report 2022: High Incidence of Gynecological Cancers, Growth in the Importance of Targeted Drug Therapies &amp; Increase in Government Investments Driving Growth &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47624"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47624\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}